دورية أكاديمية

Researches advance on anti-VEGF medication for retinopathy of prematurity

التفاصيل البيبلوغرافية
العنوان: Researches advance on anti-VEGF medication for retinopathy of prematurity
المؤلفون: Huan-Huan Zhao, Xue-Lin Huang, Su-Zhen Xie, Chao-Hui Zhao
المصدر: Guoji Yanke Zazhi, Vol 13, Iss 12, Pp 2421-2423 (2013)
بيانات النشر: Press of International Journal of Ophthalmology (IJO PRESS), 2013.
سنة النشر: 2013
المجموعة: LCC:Ophthalmology
مصطلحات موضوعية: retinopathy of prematurity, vascular endothelial growth factor, retinal neovascularization, Ophthalmology, RE1-994
الوصف: Retinopathy ofprematurity(ROP)is one of the major cause of childhood blindness worldwide. Previously, the treatment for ROP for the patients at the threshold period and before high-risk period is mainly the retinal laser and cryotherapy. However, cryotherapy and laser therapy are destructive, which can inevitably result in permanent peripheral field loss and more complications. Some patients' states of illness can't be controlled after surgery and end with total loss of vision. Hence, a new treatment method should be explored. Recently, many clinical data showed that anti-vascular endothelial growth factor therapy may be effective in treating retinopathy of prematurity. This article reviewed the recent literature on the research and progress of anti-vascular endothelial growth factor(anti-VEGF)drugs in the treatment of retinopathy of prematurity.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1672-5123
Relation: http://www.ies.net.cn/cn_publish/2013/12/201312016.pdf; https://doaj.org/toc/1672-5123
DOI: 10.3980/j.issn.1672-5123.2013.12.16
URL الوصول: https://doaj.org/article/7029a49095c447e3ba1084b80e3c56db
رقم الأكسشن: edsdoj.7029a49095c447e3ba1084b80e3c56db
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:16725123
DOI:10.3980/j.issn.1672-5123.2013.12.16